Etiket: progressionfree
GNW-Adhoc: Evaxion’s AI technology identified in phase I clinical trial of EVX-01 with longer progression-free survival of melanoma patients…
shares in this article ^* The EVX-01 Personalized Cancer Vaccine Clinical Trial has the met primary endpoints of safety and tolerability * 8 of 12 patients treated with EVX-01 had…